EcoDrugPlus

Adenosine A1 Receptor

Ensembl ID : ENSACIG00000013762
Gene Symbol: ADORA1
1 Cross references
208 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSACIG00000003958
Gene Symbol: ADORA1B
1 Cross references
201 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSACIG00000008968
Gene Symbol: ADORA2A
1 Cross references
200 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSACIG00000010778
Gene Symbol: ADORA2B
1 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSACIG00000013842
Gene Symbol: ADORA3
1 Cross references
230 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSACIG00000005466
Gene Symbol: ADA
1 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSACIG00000001354
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSACIG00000009908
Gene Symbol: ADRA1B
1 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSACIG00000005598
Gene Symbol: ADRA1BB
1 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSACIG00000001471
Gene Symbol: ADRA1D
1 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSACIG00000016481
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSACIG00000004832
Gene Symbol: ADRA2A
1 Cross references
160 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).